IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD SLE
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD SLE
批准号:
6128376
负责人:
Morris Reichlin
金额:
$30.36万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 2005-03-31
关键词:
antibody formation apoptosis autoantibody binding proteins child (0-11) clinical research disease /disorder model human subject hybridomas immunopathology laboratory mouse longitudinal human study model design /development nephritis passive immunization protein biosynthesis ribosomal proteins systemic lupus erythematosus tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract): Childhood systemic
lupus erythematosus (SLE) differs from the disease in adults by a higher
prevalence of nephritis. The investigators hypothesize that this higher
prevalence of nephritis is due to several types of nephritogenic autoantibodies
that occur concurrently in the childhood form of SLE. Two major candidates for
these autoantibodies are those directed against dsDNA which have long been
recognized to play a role in adult lupus nephritis and autoantibodies to
ribosomal "P" protein which have not been reported previously to be associated
with either adult or pediatric lupus nephritis. Aside from recent preliminary
clinical and animal data that support a role for anti-P in lupus nephritis,
both anti-dsDNA and anti-ribosomal "P" antibodies have been found to contain
subsets that directly bind and injure cells in culture. According to the
investigators, this antibody-mediated, in vitro cell injury phenomenon could be
a surrogate for their immunopathogenic potential in vivo. The investigators
propose to define the pathogenic potential of the autoantibodies in individual
patients by affinity purifying their autoantibodies and by studying their
interaction with various cell types in culture and the effects on cell function
and viability. In preliminary studies, they have reproduced previous work by
showing that some human anti-dsDNA antibodies injure cells by a complement
dependent mechanism at the cell surface, and others penetrate the cell,
localize in either the nucleus or the cytoplasm, and like anti-P, inhibit
protein synthesis. The investigators will correlate these immunopathogenetic
properties in vitro with the patients' clinical status. They propose to expand
their studies of the idiotypic regulation of these antibodies in patients with
anti-P antibodies. Parallel studies in adults suggest that, like children, the
presence of both anti-dsDNA and anti-P antibodies greatly increase the risk of
active nephritis. The investigators also have preliminary data that anti-P may
be enriched in human glomerular eluates and propose to expand these studies.
Lastly, they propose to develop an animal model to assess the nephritogenic
potential of induced anti-P antibodies. They hope that these studies would
expand perspectives on the immunopathogenesis of nephritis in both children and
adults with SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sample Procurement and Management Core
-
批准号:7938657
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2009
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7673677
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2008
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7325053
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2007
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:7125194
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IRB Inovation at a Private Research Foundation
-
批准号:6591618
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : BONE DENSITY
-
批准号:6794414
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : IMMUN DIS
-
批准号:6794417
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IMPROVEMENT OF BIOMEDICAL RESEARCH FACILITY
-
批准号:6541160
-
项目类别:
-
资助金额:$91.16万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : SLE
-
批准号:6794416
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6793968
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6531904
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : NERVOUS SYSTEM
-
批准号:6794418
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : DIABETES
-
批准号:6794415
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6949730
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6656256
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
PLANNING GRANT FOR A MULTIPURPOSE CLINICAL RES CENTER
-
批准号:6076195
-
项目类别:
-
资助金额:$16.15万
-
财政年份:1999
-
负责人:Morris Reichlin
-
依托单位:
REGULATION OF AUTOANTIBODIES TO RIBOSOMAL P PROTEINS
-
批准号:6170695
-
项目类别:
-
资助金额:$8.08万
-
财政年份:1998
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2083722
-
项目类别:
-
资助金额:$20.01万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2517517
-
项目类别:
-
资助金额:$21.27万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2769639
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: